London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I can see the similarities between this and VAL.
N4's time will hopefully come soon.
As the crpto kids say....'WenLambo???'
Keeping close eye here. Sold some recently as any deal news probably take a bit of time but I do think this will be the next big thing. Nuvec is a very different concept and is very in demand should it work. I have a large holding in VAL and that is due a deal imminently so hopefully i'll be back soon. This stocks reminds a lot of VAL which I was holding for a year as it was dead at mainly 18-22p range but a stage comes where things change. I can see that time coming here at some point soon. Good luck.
Hope so, it's a bargin at this price
Coming soon. Q4 is supposedly a 'News rich period'
Let's hope so
Oi! you just woke me up!!!!
ZZZzzzzzzzzzzzzz.......
Sure is quite here need some positive news
Oh right thanks.
Well i'm always glad to get any snippets like that, hopefully Nigel was in good form and increasingly optimistic. Cheers Dan.
Johno the message has been deleted - DanBaker was claiming to have spoken to Nigel yesterday- blah blah blah so I called his bluff and made a suggestion - then all of a sudden the message has gone
Lets sincerely hope so..been here since the ONZ days...not going anywhere till the end
When this pays off ( in my opinion by the end of this year) , there's a select few people I know of who are holding nice amounts, who will be very wealthy come end of Q4. For anyone who asks why the end of the year. Check what results are concluding Q4, and yes the product won't be complete but the foundations will have been secured and very desirable which we will see greatly in the SP.
What comments from Dan, has a post been deleted?
Dan, thank you for your comments, but could you speak to Nigel and as for a video via the website or a tweet for him to do a personalised message to all investors to explain the progress that has been made without naming the big pharma as people have made there own conclusions as to who it is ie GSK being one of them.
The chat would not be via directors talk but a 121 message from the CEO, this will show he’s on top of things plus he could say if the presentation went well with all the other big pharma’s.
Least then he can do a bit of his own PR on a product we know can help the world.
Hall agree with u and Dan, its sad to see long termer left last week after holding for 5 years...
Thanks for the update Dan. Confidence grows week by week with N4P.
Fingers crossed we'll get there one day Maz
Been with N4P for 4 years, feel we soon will be successful, Acceleration in our understanding of the capabilities of Nuvec(R) following our optimisation work. This has been coupled with our first MTAs which, in turn and together with results elsewhere, led us to review the scope of the recently commenced in vivo work with Evotec pushing some of this work into the second half of this financial year.
"Our strategy remains the same as it always has and that is to generate sufficient proof of concept data with a view to attracting large pharma and biotech partners to enter into collaborations to explore using Nuvec(R) as their chosen delivery system. The issues facing mRNA Covid vaccines in respect of storage and distribution are well known following the Corona virus pandemic. DNA vaccines are more stable than mRNA yet need to use a much higher dose due to the delivery systems currently chosen. Demonstrating suitable efficacy whilst addressing the storage and dosage issues would, we believe, greatly enhance Nuvec(R) as a potential delivery tool for vaccines in the eyes of collaborators.
It all requires Nuvec as vaccine delivery system, covid, malaria, or flu or sars....IMO at MCap of £12 M its a joke..